Globus Medical (GMED) Reports In-Line Q3 EPS

November 8, 2016 4:22 PM EST
Get Alerts GMED Hot Sheet
Trade GMED Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Globus Medical (NYSE: GMED) reported Q3 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $139.25 million.

GUIDANCE:

Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus Medical sees FY2016 revenue of $560 million, versus the consensus of $574.79 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment